These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 2110560

  • 21. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP, Boyer WF, Meredith CH, Hendrickson GG.
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [Abstract] [Full Text] [Related]

  • 22. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS.
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [Abstract] [Full Text] [Related]

  • 23. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD.
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [Abstract] [Full Text] [Related]

  • 24. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P, Hardison CD.
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [Abstract] [Full Text] [Related]

  • 25. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R, Van Moffaert M, Mesotten F, Ansseau M, Uytdenhoef P, Bartholome F.
    Acta Psychiatr Belg; 1985 Mar; 85(5):636-43. PubMed ID: 3937441
    [Abstract] [Full Text] [Related]

  • 26. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N, Ravic M, Bizière K.
    Drugs Exp Clin Res; 1987 Mar; 13(7):435-42. PubMed ID: 3308390
    [Abstract] [Full Text] [Related]

  • 27. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 Mar; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 28. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 Mar; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 29. Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
    Cassano GB, Conti L, Massimetti G, Mengali F, Waekelin JS, Levine J.
    Psychopharmacol Bull; 1986 Mar; 22(1):52-8. PubMed ID: 3088668
    [No Abstract] [Full Text] [Related]

  • 30. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH, Feighner JP, Hendrickson G.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [Abstract] [Full Text] [Related]

  • 31. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, Meya U, Sastre-y-Hernández M, Schöny W, Schratzer M, Soukop W.
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [Abstract] [Full Text] [Related]

  • 32. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Jul; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 33. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J, Schless AP.
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [Abstract] [Full Text] [Related]

  • 34. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF, Putman HP.
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [Abstract] [Full Text] [Related]

  • 35. An outpatient evaluation of phenelzine and imipramine.
    Davidson J, Raft D, Pelton S.
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [Abstract] [Full Text] [Related]

  • 36. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE, Biggs J, Jacobs M, Holden K.
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [Abstract] [Full Text] [Related]

  • 37. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS, Perel JM, Pollock BG, Kupfer DJ.
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [Abstract] [Full Text] [Related]

  • 38. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 39. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
    Gonella G, Baignoli G, Ecari U.
    Curr Med Res Opin; 1990 Dec; 12(3):177-84. PubMed ID: 2125547
    [Abstract] [Full Text] [Related]

  • 40. Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice.
    Hamilton BA, Jones PG, Hoda AN, Keane PM, Majid I, Zaidi SI.
    Pharmatherapeutica; 1989 Dec; 5(5):292-7. PubMed ID: 2501801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.